These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31586902)

  • 1. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation.
    Wang J; Su G; Yin X; Luo J; Gu R; Wang S; Feng J; Chen B
    Biomed Pharmacother; 2019 Dec; 120():109493. PubMed ID: 31586902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer.
    Lu X; Liu S; Han M; Yang X; Sun K; Wang H; Mu H; Du Y; Wang A; Ni L; Zhang C
    Int J Pharm; 2019 Apr; 560():126-135. PubMed ID: 30742982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
    Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
    J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
    Elbatanony RS; Parvathaneni V; Kulkarni NS; Shukla SK; Chauhan G; Kunda NK; Gupta V
    Drug Deliv Transl Res; 2021 Jun; 11(3):927-943. PubMed ID: 32557351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
    Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer.
    Yang Y; Huang Z; Li J; Mo Z; Huang Y; Ma C; Wang W; Pan X; Wu C
    Adv Healthc Mater; 2019 Dec; 8(23):e1900965. PubMed ID: 31664795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.
    Tan S; Wang G
    Drug Des Devel Ther; 2017; 11():3519-3529. PubMed ID: 29263650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
    Wang J
    Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
    Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
    Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab.
    Pang J; Xing H; Sun Y; Feng S; Wang S
    Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
    Liu Y; Liu J; Liang J; Zhang M; Li Z; Wang Z; Dang B; Feng N
    Nanomedicine; 2017 Oct; 13(7):2219-2229. PubMed ID: 28539275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.
    Wang L; You X; Lou Q; He S; Zhang J; Dai C; Zhao M; Zhao M; Hu H; Wu J
    Biomater Sci; 2019 Oct; 7(10):4218-4229. PubMed ID: 31389415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.